Tau in Alzheimer's Disease and Down's Syndrome is Insoluble and Abnormally Phosphorylated

Overview

Journal Biochem J

Specialty Biochemistry

Date 1991 Apr 1

PMID 1826835

Citations 30

Authors

D P Hanger

J P Brion

J M Gallo

N J Cairns

P J Luthert

B H Anderton

Affiliations

Soon will be listed here.

Abstract

Some investigators have described the presence in Alzheimer's disease brain extracts of several abnormal forms of the microtubule-associated protein tau, based on their unusual mobility in SDS/PAGE. It has been proposed that these abnormal forms of tau may be the result of aberrant tau phosphorylation. In this study we show that tau in extracts of Alzheimer's disease brain can be separated into two fractions based upon its solubility (100,000 g x 1 h supernatant) in non-denaturing conditions (100 mM-Mes, pH 6.5, 0.5 mM-MgCl2, 1 mM-EGTA and 1 M-NaCl). The tau isoforms with decreased mobility in SDS/PAGE are predominantly in an insoluble fraction, whereas the soluble tau is indistinguishable by its mobility in SDS/PAGE from tau in soluble extracts of control brain. Insoluble tau displaying abnormal mobility on SDS/PAGE was only found in Alzheimer and adult Down's syndrome brains and was absent from the brains of age-matched controls and from foetal and infant Down's syndrome brains. There was a good correlation between the presence of insoluble tau in brain extracts and the abundance of neurofibrillary tangles and senile neuritic plaques. The monoclonal antibody Tau. 1 stained insoluble tau on Western blots only after treatment of the nitrocellulose transfers with alkaline phosphatase, implying that this insoluble tau is in a particular state of phosphorylation. We conclude that, in Alzheimer's disease, a fraction of tau has a modified phosphorylation state and a decreased solubility; these modifications may precede formation of the neurofibrillary tangles characteristic of Alzheimer's disease and Down's syndrome in adults.

Citing Articles

Cryo-EM structures reveal tau filaments from Down syndrome adopt Alzheimer's disease fold.

Ghosh U, Tse E, Yang H, Shi M, Caro C, Wang F Acta Neuropathol Commun. 2024; 12(1):94.

PMID: 38867338 PMC: 11167798. DOI: 10.1186/s40478-024-01806-y.

Amyloid-beta and tau protein beyond Alzheimer's disease.

Abyadeh M, Gupta V, Paulo J, Mahmoudabad A, Shadfar S, Mirshahvaladi S Neural Regen Res. 2023; 19(6):1262-1276.

PMID: 37905874 PMC: 11467936. DOI: 10.4103/1673-5374.386406.

Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation .

Ondrejcak T, Klyubin I, Hu N, OMalley T, Corbett G, Winters R J Neurosci. 2023; 43(32):5870-5879.

PMID: 37491315 PMC: 10423043. DOI: 10.1523/JNEUROSCI.0082-23.2023.

Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length.

Walker C, Greathouse K, Tuscher J, Dammer E, Weber A, Liu E J Neurosci. 2023; 43(20):3764-3785.

PMID: 37055180 PMC: 10198456. DOI: 10.1523/JNEUROSCI.2102-22.2023.

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.

Zhang S, Zhu Y, Lu J, Liu Z, Lobato A, Zeng W Elife. 2022; 11.

PMID: 36048712 PMC: 9436411. DOI: 10.7554/eLife.79898.

References

Brion J, Hanger D, Bruce M, Couck A, FLAMENT-DURAND J, Anderton B . Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site. Biochem J. 1991; 273(Pt 1):127-33. PMC: 1150212. DOI: 10.1042/bj2730127. View

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Wischik C, Crowther R, Stewart M, Roth M . Subunit structure of paired helical filaments in Alzheimer's disease. J Cell Biol. 1985; 100(6):1905-12. PMC: 2113596. DOI: 10.1083/jcb.100.6.1905. View

Kosik K, Orecchio L, Binder L, Trojanowski J, Lee V, Lee G . Epitopes that span the tau molecule are shared with paired helical filaments. Neuron. 1988; 1(9):817-25. DOI: 10.1016/0896-6273(88)90129-8. View

Nukina N . The reinterpretation of the immunochemical study of Alzheimer neurofibrillary tangles. Ann Med. 1989; 21(2):117-9. DOI: 10.3109/07853898909149197. View

Flament S, Delacourte A, Hemon B, Defossez A . Characterization of two pathological tau protein, variants in Alzheimer brain cortices. J Neurol Sci. 1989; 92(2-3):133-41. DOI: 10.1016/0022-510x(89)90131-7. View

Parent M, Delacourte A, Defossez A, Hemon B, Han K, Petit H . [Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue]. C R Acad Sci III. 1988; 306(13):391-7. View

Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G . Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res. 1989; 477(1-2):90-9. DOI: 10.1016/0006-8993(89)91396-6. View

Mori H, Hamada Y, Kawaguchi M, Honda T, Kondo J, Ihara Y . A distinct form of tau is selectively incorporated into Alzheimer's paired helical filaments. Biochem Biophys Res Commun. 1989; 159(3):1221-6. DOI: 10.1016/0006-291x(89)92240-7. View

10.

Flament S, Delacourte A, Hemon B, Defossez A . [Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease]. C R Acad Sci III. 1989; 308(3):77-82. View

11.

Wischik C, Novak M, Thogersen H, Edwards P, Runswick M, Jakes R . Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc Natl Acad Sci U S A. 1988; 85(12):4506-10. PMC: 280459. DOI: 10.1073/pnas.85.12.4506. View

12.

Flament S, Delacourte A . Abnormal tau species are produced during Alzheimer's disease neurodegenerating process. FEBS Lett. 1989; 247(2):213-6. DOI: 10.1016/0014-5793(89)81337-7. View

13.

Gray E, Roher A . Alzheimer's disease: paired helical filaments and cytomembranes. Neuropathol Appl Neurobiol. 1987; 13(2):91-110. DOI: 10.1111/j.1365-2990.1987.tb00174.x. View

14.

Delacourte A, Defossez A . Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments. J Neurol Sci. 1986; 76(2-3):173-86. DOI: 10.1016/0022-510x(86)90167-x. View

15.

Iqbal K, Grundke-Iqbal I, Zaidi T, Merz P, Wen G, Shaikh S . Defective brain microtubule assembly in Alzheimer's disease. Lancet. 1986; 2(8504):421-6. DOI: 10.1016/s0140-6736(86)92134-3. View

16.

Baudier J, Cole R . Phosphorylation of tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J Biol Chem. 1987; 262(36):17577-83. View

17.

Wolozin B, Pruchnicki A, Dickson D, Davies P . A neuronal antigen in the brains of Alzheimer patients. Science. 1986; 232(4750):648-50. DOI: 10.1126/science.3083509. View

18.

Kosik K, Joachim C, Selkoe D . Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A. 1986; 83(11):4044-8. PMC: 323662. DOI: 10.1073/pnas.83.11.4044. View

19.

Wood J, Mirra S, Pollock N, Binder L . Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc Natl Acad Sci U S A. 1986; 83(11):4040-3. PMC: 323661. DOI: 10.1073/pnas.83.11.4040. View

20.

Grundke-Iqbal I, Iqbal K, Tung Y, Quinlan M, Wisniewski H, Binder L . Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986; 83(13):4913-7. PMC: 323854. DOI: 10.1073/pnas.83.13.4913. View